Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of the Medical Sciences

• Publication date

  2016-02-17

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor immunology and immunotherapy

  2014cited by this paper
• Graft-versus-host disease.

  2009cited by this paper
• Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

  2008cited by this paper
• A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.

  2008cited by this paper
• Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008cited by this paper
• Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer.

  2008cited by this paper
• CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.

  2008cited by this paper
• T-cell therapy after hematopoietic stem cell transplantation

  2007cited by this paper
• Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD 8 + T cells

  2007cited by this paper
• Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

  2007cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• Specificity of T-cell alloreactivity

  2007cited by this paper
• Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.

  2007cited by this paper
• Captopril, an Angiotensin-Converting Enzyme Inhibitor, Promotes Growth of Immunogenic Tumors in Mice

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• CD8+ T‐cell memory in tumor immunology and immunotherapy

  2006cited by this paper
• Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.

  2006cited by this paper
• Adoptive immunotherapy for cancer: building on success

  2006cited by this paper
• Adoptive cellular immunotherapy of cancer in mice using allogeneic T-cells

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• Glucocorticoids Do Not Inhibit Antitumor Activity of Activated CD8+ T Cells

  2005cited by this paper
• Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

  2005cited by this paper
• Telomere Length of Transferred Lymphocytes Correlates with In Vivo Persistence and Tumor Regression in Melanoma Patients Receiving Cell Transfer Therapy1

  2005cited by this paper
• Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

  2005cited by this paper
• CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors

  2005cited by this paper
• Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression

  2005cited by this paper
• Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

  2005cited by this paper
• Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation.

  2005cited by this paper
• Primary antitumor immune response mediated by CD4+ T cells.

  2005cited by this paper
• Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.

  2004cited by this paper
• CD8 T cell memory.

  2004cited by this paper
• Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity

  2004cited by this paper
• Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients

  2003cited by this paper
• Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

  2003cited by this paper
• CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

  2003cited by this paper
• Memory CD4+ T cells do not induce graft-versus-host disease.

  2003cited by this paper
• Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.

  2002cited by this paper
• Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation.

  2000cited by this paper
• Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope

  2000cited by this paper
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

  1998cited by this paper
• Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.

  1996cited by this paper
• Fludarabine treatment and transfusion-associated graft-versus-host disease.

  1996cited by this paper
• Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation.

  1995cited by this paper
• Detection of circulating donor white blood cells in patients receiving multiple transfusions.

  1992cited by this paper
• Tumor immunology and immunotherapy

  1977cited by this paper

• No citing papers are available for this paper.